BlackRock Inc.
- SEC CIK
- 0001364742
- Latest filing
- Aug 13, 2024
CATX holding history
Perspective Therapeutics, Inc. in every 13F filed by BlackRock Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CATX overviewAll 13F holders of CATXFull Q2 2024 holdings
- Shares (Q2 2024)
- 3,485,946
- Value
- $34.8M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 3,485,946 | $34.8M | <0.1% | −4,408,739−55.8% | Reduced | Holders |
| Q1 2024 | 7,894,685 | $9.39M | <0.1% | +3,356,296+74.0% | Added | Holders |
| Q4 2023 | 4,538,389 | $1.82M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 4,538,389 | $1.24M | <0.1% | −799,393−15.0% | Reduced | Holders |
| Q2 2023 | 5,337,782 | $3.57M | <0.1% | +333,449+6.7% | Added | Holders |
| Q1 2023 | 5,004,333 | $3.19M | <0.1% | +2,546,765+103.6% | Added | Holders |
| Q4 2022 | 2,457,568 | $607.3K | <0.1% | +14,224+0.6% | Added | Holders |
| Q3 2022 | 2,443,344 | $562.0K | <0.1% | −2,009−0.1% | Reduced | Holders |
| Q2 2022 | 2,445,353 | $756.0K | <0.1% | +6,135+0.3% | Added | Holders |
| Q1 2022 | 2,439,218 | $885.0K | <0.1% | +9450.0% | Added | Holders |
| Q4 2021 | 2,438,273 | $945.0K | <0.1% | −24,522−1.0% | Reduced | Holders |
| Q3 2021 | 2,462,795 | $1.55M | <0.1% | −2890.0% | Reduced | Holders |
| Q2 2021 | 2,463,084 | $1.97M | <0.1% | −577,476−19.0% | Reduced | Holders |
| Q1 2021 | 3,040,560 | $3.31M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.